Connection

Andree Kurniawan to Severity of Illness Index

Back to Details
This is a "connection" page, showing publications Andree Kurniawan has written about Severity of Illness Index.
Andree Kurniawan
Connection Strength
0.127
Severity of Illness Index
  1. Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis. Drug Res (Stuttg). 2021 May; 71(5):265-274.
    View in: PubMed
    Score: 0.030
  2. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis. Am J Emerg Med. 2021 Mar; 41:110-119.
    View in: PubMed
    Score: 0.030
  3. Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection. J Med Virol. 2021 03; 93(3):1832-1836.
    View in: PubMed
    Score: 0.030
  4. Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection. Dig Liver Dis. 2020 12; 52(12):1410-1412.
    View in: PubMed
    Score: 0.030
  5. Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19. Cytokine. 2021 02; 138:155393.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.